Xudong Ding

719 total citations
36 papers, 563 citations indexed

About

Xudong Ding is a scholar working on Molecular Biology, Neurology and Surgery. According to data from OpenAlex, Xudong Ding has authored 36 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Neurology and 6 papers in Surgery. Recurrent topics in Xudong Ding's work include Botulinum Toxin and Related Neurological Disorders (6 papers), Ferroptosis and cancer prognosis (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Xudong Ding is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (6 papers), Ferroptosis and cancer prognosis (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Xudong Ding collaborates with scholars based in China, United States and Japan. Xudong Ding's co-authors include José R. López, Paul D. Allen, José M. Eltit, Ningning Zheng, Ningning Zheng, Isaac N. Pessah, Haijun Hu, Dongmei Sun, Fang Miao and Wei Sun and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Life Sciences.

In The Last Decade

Xudong Ding

36 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xudong Ding China 13 270 81 69 67 57 36 563
Alessio Alfieri United Kingdom 13 412 1.5× 65 0.8× 67 1.0× 48 0.7× 50 0.9× 20 852
Zohara Sternberg United States 16 170 0.6× 108 1.3× 35 0.5× 36 0.5× 89 1.6× 39 713
Shahnawaz Ali Bhat India 15 255 0.9× 111 1.4× 75 1.1× 133 2.0× 116 2.0× 31 766
Pengwei Zhuang China 16 279 1.0× 93 1.1× 75 1.1× 72 1.1× 33 0.6× 39 706
Shin-Young Ryu United States 15 594 2.2× 147 1.8× 47 0.7× 150 2.2× 79 1.4× 16 875
Lu Ren China 14 333 1.2× 133 1.6× 60 0.9× 44 0.7× 62 1.1× 52 858
Yilu Ye China 16 238 0.9× 85 1.0× 103 1.5× 69 1.0× 23 0.4× 40 658
Shanhong Zhao China 18 218 0.8× 300 3.7× 56 0.8× 112 1.7× 37 0.6× 24 657
Caner Günaydın Türkiye 11 168 0.6× 46 0.6× 99 1.4× 70 1.0× 13 0.2× 26 519

Countries citing papers authored by Xudong Ding

Since Specialization
Citations

This map shows the geographic impact of Xudong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xudong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xudong Ding more than expected).

Fields of papers citing papers by Xudong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xudong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xudong Ding. The network helps show where Xudong Ding may publish in the future.

Co-authorship network of co-authors of Xudong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xudong Ding. A scholar is included among the top collaborators of Xudong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xudong Ding. Xudong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Lian, Wenbo Zhao, Tiantian Han, et al.. (2024). Ropivacaine prompts ferroptosis to enhance the cisplatin-sensitivity of human colorectal cancer through SIRT1/Nrf2 signaling pathway. Chemico-Biological Interactions. 400. 111163–111163. 4 indexed citations
2.
Zeng, Lian, Yanping Liu, Qingsong Wang, et al.. (2024). Botulinum toxin A attenuates osteoarthritis development via inhibiting chondrocyte ferroptosis through SLC7Al1/GPX4 axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167215–167215. 12 indexed citations
3.
Zhang, Zheming, et al.. (2024). Empagliflozin, a sodium‐glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome. Journal of Cellular Physiology. 239(6). e31264–e31264. 1 indexed citations
4.
Li, Hong, et al.. (2023). Intestinal metabolites and the risk of autistic spectrum disorder: A two-sample Mendelian randomization study. Frontiers in Psychiatry. 13. 1034214–1034214. 9 indexed citations
5.
Ding, Xudong, et al.. (2023). Mitochondrial DNA abnormalities and metabolic syndrome. Frontiers in Cell and Developmental Biology. 11. 1153174–1153174. 10 indexed citations
6.
Li, Sisi, Yangfan Qi, Jiachuan Yu, et al.. (2023). Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer. Heliyon. 9(7). e17386–e17386. 4 indexed citations
7.
Zeng, Lian, Chenguang Liu, Zhen Zhang, et al.. (2022). Melatonin Attenuates Ropivacaine-Induced Apoptosis by Inhibiting Excessive Mitophagy Through the Parkin/PINK1 Pathway in PC12 and HT22 Cells. Inflammation. 45(2). 725–738. 15 indexed citations
8.
9.
Zheng, Ningning, et al.. (2021). Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress. Heart Failure Reviews. 27(4). 1387–1394. 54 indexed citations
10.
Zheng, Ningning, et al.. (2021). Mitophagy Disequilibrium, a Prominent Pathological Mechanism in Metabolic Heart Diseases. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4631–4640. 12 indexed citations
11.
Sang, Ming, Xuanbin Wang, Hanyao Zhang, et al.. (2017). Gene Expression Profile of Peripheral Blood Mononuclear Cells in Response to Intracerebral Hemorrhage. DNA and Cell Biology. 36(8). 647–654. 14 indexed citations
12.
Ding, Xudong, et al.. (2017). Impact of Botox-A SNAP-25 protein expression and the mechanism of inhibitory neurotransmitter imbalance in chronic sciatic nerve pain rat model. Experimental and Therapeutic Medicine. 13(6). 2783–2786. 1 indexed citations
13.
Ding, Xudong, et al.. (2015). Treatment of Benign Prostatic Hyperplasia by Ultrasound-Guided Botulinum Toxin Type A Injection. Cell Biochemistry and Biophysics. 73(2). 357–359. 3 indexed citations
14.
Ding, Xudong, et al.. (2015). Dexmedetomidine preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest. International Journal of Neuroscience. 126(3). 249–256. 21 indexed citations
15.
Ding, Xudong, Huaxian Chen, Wei Wang, Han Wang, & Li Huang. (2014). The effect of botulinum toxin type A injection with ankle-foot orthosis on patients with post-stroke lower limb spasticity. Zhonghua wuli yixue zazhi. 36(5). 349–352. 2 indexed citations
16.
Altamirano, Francisco, José M. Eltit, Gaëlle Robin, et al.. (2014). Ca2+ Influx via the Na+/Ca2+ Exchanger Is Enhanced in Malignant Hyperthermia Skeletal Muscle. Journal of Biological Chemistry. 289(27). 19180–19190. 26 indexed citations
17.
Ding, Xudong, et al.. (2014). Intrathecal lidocaine neurotoxicity: Combination with bupivacaine and ropivacaine and effect of nerve growth factor. Life Sciences. 112(1-2). 10–21. 21 indexed citations
18.
Zheng, Ningning, et al.. (2014). Low Concentration of Rapamycin Inhibits Hemangioma Endothelial Cell Proliferation, Migration, and Vascular Tumor Formation in Mice. Current Therapeutic Research. 76. 99–103. 22 indexed citations
19.
Zheng, Ningning, et al.. (2012). Targeting rictor inhibits mouse vascular tumor cell proliferation and invasion in vitro and tumor growth in vivo. Neoplasma. 60(1). 41–45. 5 indexed citations
20.
Miao, Fang, Xin‐Juan Yang, Le Zhou, et al.. (2011). Structural modification of sanguinarine and chelerythrine and their antibacterial activity. Natural Product Research. 25(9). 863–875. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessio Alfieri Breakdown of academic impact, for papers by Zohara Sternberg Breakdown of academic impact, for papers by Shahnawaz Ali Bhat Breakdown of academic impact, for papers by Pengwei Zhuang Breakdown of academic impact, for papers by Shin-Young Ryu Breakdown of academic impact, for papers by Lu Ren Breakdown of academic impact, for papers by Yilu Ye Breakdown of academic impact, for papers by Shanhong Zhao Breakdown of academic impact, for papers by Caner Günaydın
Rankless by CCL
2026